Shaping the future of immunodeficiency care, with Dr Jörg Sc...
Dr Jörg Schüttrumpf, Chief Scientific Innovation Officer of Grifols, discusses advancing immunoglobulin (or IG) treatment for immune disorders.
Newsletters and Deep Dive digital magazine
Dr Jörg Schüttrumpf, Chief Scientific Innovation Officer of Grifols, discusses advancing immunoglobulin (or IG) treatment for immune disorders.
Andrew Newland, former CEO of ANGLE, explains why live cell liquid biopsies should become standard in oncology.
Vinay Patel, an innovative pharmacist, discuss the intricacies of drug pricing and accessibility in the US.
Tarek Samad, Lundbeck’s senior vice president and head of research, discusses AI – specifically, Lundbeck’s agreement with the DCAI to operate Gefion.
Markus Vossman, Germany general manager at Illumina, discusses innovative genomic applications and projects in the region.
Editor's Picks
Newsletters and Deep Dive
digital magazine